Related Experiment Video
Updated: Aug 17, 2026
An In Vitro Approach to Photodynamic Therapy
Published on: August 17, 2018
Photodynamic therapy of head and neck basal cell carcinoma according to different clinicopathologic features
Ahmad Kaviani1, Leila Ataie-Fashtami, Mohsen Fateh
1Tehran University of Medical Sciences and Iranian Center for Medical Laser Research, Tehran, Iran. akaviani@sina.tums.ac.ir
Background And Objectives:
We aimed to treat different pathologic types of basal cell carcinomas (BCCs) using photodynamic therapy (PDT).
Study Design/Materials And Methods:
Thirty lesions in six patients underwent PDT. The photosensitizer used was Photoheme, a hematoporphyrin derivative IX. It was injected intravenously at the dose of 2-3.25 mg/kg. After 24 hours, the lesions were illuminated by laser light (lambda = 632 nm, light exposure dose = 100-200 J/cm2). Lesions were evaluated pre and post-operatively and at follow-up sessions (of up to 6 months).
Results:
After a single session of PDT, the average response rate in different histopathologic kinds of basal cell carcinoma (e.g., ulcerative, superficial, nodular, and pigmented forms) were 100%, 62%, 90%, and 14%, respectively. In patients who responded completely, the cosmetic results were excellent and there were no recurrence at 6th month of follow-up.
Conclusion:
Although PDT seems to be an effective treatment modality for superficial, ulcerative, and nodular BCCs, it is not recommended for pigmented lesions.
